| 000 | 01713 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513151633.0 | ||
| 264 | 0 | _c19980910 | |
| 008 | 199809s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(98)00126-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoedemaekers, A | |
| 245 | 0 | 0 |
_aRole of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cAug 1998 |
||
| 300 |
_a131-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAging _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAutoimmunity _ximmunology |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression _ximmunology |
| 650 | 0 | 4 | _aMuscle Denervation |
| 650 | 0 | 4 |
_aMuscle, Skeletal _ximmunology |
| 650 | 0 | 4 |
_aMyasthenia Gravis _ximmunology |
| 650 | 0 | 4 |
_aNeuromuscular Junction _xchemistry |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred BN |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _xgenetics |
| 650 | 0 | 4 |
_aSciatic Nerve _xsurgery |
| 650 | 0 | 4 |
_aSynapses _xchemistry |
| 650 | 0 | 4 |
_aUp-Regulation _xgenetics |
| 700 | 1 | _aBessereau, J L | |
| 700 | 1 | _aGraus, Y | |
| 700 | 1 | _aGuyon, T | |
| 700 | 1 | _aChangeux, J P | |
| 700 | 1 | _aBerrih-Aknin, S | |
| 700 | 1 | _avan Breda Vriesman, P | |
| 700 | 1 | _aDe Baets, M H | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 89 _gno. 1-2 _gp. 131-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(98)00126-x _zAvailable from publisher's website |
| 999 |
_c9692031 _d9692031 |
||